You are here: Home1 / Transparency2 / Healthcare Professionals & Healthcare Organisations3 / 2019 Transfers of Value
The Mitsubishi Tanabe Pharma Group engages Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) across Europe.
We are committed to ensuring transparency in our interaction with HCPs and HCOs. In accordance with the EFPIA Code of Transfers of Value from Pharmaceutical Companies 2014, details of Transfers of Value made to HCPs and HCOs in Europe by the Mitsubishi Tanabe Pharma Group can be found below.
The Methodology applied in preparing and collating these figures is available here in English*, French* and German*.
If you are a Healthcare Professional and have any questions regarding the figures disclosed, please contact:
Finance@mt-pharma-eu.com.
2019 Transfers of Value
| Austria | |
|---|---|
| Research & Development | €11,216.00 |
| Non-Research & Development | €126,341.66 |
| Full details here | |
| Belgium | |
|---|---|
| Research & Development | €23,031.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Bulgaria | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Croatia | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Cyprus | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Czech Republic | |
|---|---|
| Research & Development | 0.00 CZK |
| Non-Research & Development | 0.00 CZK |
| Full details here | |
| Denmark | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Estonia | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Finland | |
|---|---|
| Research & Development | €1,656,166.27 |
| Non-Research & Development | €0.00 |
| Full details here | |
| France | |
|---|---|
| Research & Development | €859,827.60 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Germany | |
|---|---|
| Research & Development | €4,244,818.30 |
| Non-Research & Development | €77,863.08 |
| Full details here | |
| Greece | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Hungary | |
|---|---|
| Research & Development | 483,051.85 HUF |
| Non-Research & Development | 0.00 HUF |
| Full details here | |
| Ireland | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Italy | |
|---|---|
| Research & Development | €1,003,666.20 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Latvia | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Lithuania | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Malta | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| The Netherlands | |
|---|---|
| Research & Development | €6,530.00 |
| Non-Research & Development | €0.0 |
| Full details here | |
| Norway | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Poland | |
|---|---|
| Research & Development | €52,154.04 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Portugal | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Romania | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Russia | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Serbia | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Slovakia | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Slovenia | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Spain | |
|---|---|
| Research & Development | €2,400.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Sweden | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €10,909.03 |
| Full details here | |
| Switzerland | |
|---|---|
| Research & Development | 57,547.00 CHF |
| Non-Research & Development | 133,817.80 CHF |
| Full details here | |
| Turkey | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| Ukraine | |
|---|---|
| Research & Development | €0.00 |
| Non-Research & Development | €0.00 |
| Full details here | |
| United Kingdom | |
|---|---|
| Research & Development | £71,697.09 |
| Non-Research & Development | £70,046.87 |
| Full details here or here (ABPI Website) | |
* The Mitsubishi Tanabe Pharma Group has established legal entities in the United Kingdom, Germany and Switzerland and therefore disclosure is made according to local requirements for these countries
Terms and Privacy
Contact Us
Mitsubishi TANABE Pharma Europe Ltd
Dashwood House
69 Old Broad Street
London
EC2M 1QS
United Kingdom